Open AccessPB2179: RETROSPECTIVE ANALYSIS OF THE EFFICACY AND SAFETY OF RUXOLITINIB IN CHRONIC GRAFT VERSUS HOST DISEASE (CGVHD). A SINGLE‐INSTITUTION EXPERIENCE.
Author(s) -
Muñiz Ó.,
Torrado Chedas T.,
Nieto Vazquez A.,
Santamaria Lopez A.,
Winsnes E.,
González Rodríguez L.,
Albo Lopez C.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000851544.57756.33
Subject(s) - medicine , ruxolitinib , graft versus host disease , common terminology criteria for adverse events , hematopoietic stem cell transplantation , retrospective cohort study , salvage therapy , cohort , adverse effect , transplantation , surgery , chemotherapy , myelofibrosis , bone marrow